Muscles cannot contribute to raising blood glucose by glycogenolysis due to lack of –
**Question:** Muscles cannot contribute to raising blood glucose by glycogenolysis due to lack of -
**Core Concept:** Glycogenolysis is the process by which glycogen stored in the liver and muscles is broken down into glucose-6-phosphate, which can be further converted into glucose for immediate energy release and blood glucose regulation.
**Why the Correct Answer is Right:** Glycogenolysis occurs in response to hormonal and cellular signals, primarily triggered by low blood glucose levels and muscle contraction. However, in muscles, glycogenolysis is less prominent due to the absence of two key factors:
1. **Glycogen phosphorylase kinase (GPK) activity:** This enzyme is essential for activating glycogen phosphorylase, which breaks down glycogen into glucose-6-phosphate. GPK is primarily located in the liver and not in muscles, thus limiting glycogenolysis in muscles.
2. **Glucagon:** Glucagon is a hormone released by the pancreas in response to low blood glucose levels. In muscles, glucagon does not exert its effect, as it cannot cross the sarcolemma (the outermost layer of muscle cells) due to its large molecular weight.
**Why Each Wrong Option is Incorrect:**
A. Glucose-6-phosphatase: This enzyme is involved in the final step of glycogenolysis, converting glucose-6-phosphate back into glucose. Although glucose-6-phosphatase is present in both liver and muscle cells, its role is primarily in the liver to recycle glucose-6-phosphate back to glucose, rather than in glycogenolysis in muscles.
B. Insulin: Insulin is a hormone that promotes glucose uptake by muscle cells, but it does not inhibit glycogenolysis. In fact, in the liver, insulin inhibits glycogenolysis to stabilize blood glucose levels.
C. Liver: Although glycogenolysis primarily occurs in the liver, it is not exclusively limited to the liver. Muscles can also undergo glycogenolysis, but the process is less effective due to the lack of GPK and glucagon.
D. Sarcolemma: The sarcolemma of skeletal muscle cells acts as a selective barrier to glucose uptake and insulin signaling, preventing insulin from inhibiting glycogenolysis in muscle cells.
**Clinical Pearls:**
1. In clinical scenarios such as fasting, trauma, or intense exercise, glycogenolysis occurs primarily in the liver, resulting in glucose release into the bloodstream to maintain blood glucose levels and provide energy for the body.
2. While glycogenolysis can occur in muscles, it is less efficient due to the absence of key enzymes and hormones involved in the process, such as GPK and glucagon.
3. Insulin plays a crucial role in regulating blood glucose levels by promoting glucose uptake by muscle cells, but it does not inhibit glycogenolysis in muscles.
4. In contrast to the liver, muscle cells have lower levels of enzymes and hormones involved in glycogenolysis, limiting the process's effectiveness in these cells.
**Core Concept:** Glycogenolysis is a crucial process in maintaining blood glucose levels, and its efficient functioning depends on the presence of specific enzymes (GPK) and hormones (glucagon